Archives

by in
Entry Author Date Location
Buy Your Ticket Now for VC65 on April 6 and Get a Free Copy of Bill Draper’s Book, The Startup Game 03/21/11 Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News 03/18/11 Boston
World Energy Backs Retroficiency, American Superconductor Gets Finnish Firm, BuyWithMe Buys LocalTwist, & More Boston-Area Deals News 03/16/11 Boston
Living Proof Shines With $16M 03/14/11 Boston
VC65 to Feature Tales of Great VCs and Entrepreneurs—Come Wish Venture Capital a Happy Birthday at MIT’s Kresge Auditorium 03/08/11 Boston
Pervasis in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says 02/01/11 Boston
Relay: An App for Finding the Next Top Scientists and Discoveries 01/04/11 Boston
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats 12/14/10 Boston
Semprus Scores $18M More to Help Improve Medical Devices 12/13/10 Boston
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News 11/18/10 Boston
$3M for Kala Pharmaceuticals 11/12/10 Boston
InVivo Completes Reverse Merger, Raising $10.5M 10/27/10 Boston
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences 08/16/10 Boston
In-Q-Tel, the CIA’s Investment Arm, Quietly Backing Seventh Sense Biosystems 08/05/10 Boston
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Logical and Arsenal Get $10M Apiece, Constant Contact Acquires NutshellMail, Avila Gets $209M From Clovis, & More Boston-Area Deals News 05/26/10 Boston
Vertex Awaits Results of Hepatitis C Drug Trial, Helicos and Pfizer Cut Jobs, St. Jude Acquires LightLab, & More Boston-Area Life Sciences News 05/21/10 Boston
Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain 05/20/10 Boston
Arsenal Medical, Startup Linked to Langer and Whitesides, Adds $10M 05/19/10 Boston
Selecta Biosciences, a Bob Langer Creation, Raises $15M For Nanoparticle Vaccines 04/05/10 Boston
Bonding with BIND Biosciences’s New CEO Scott Minick 01/15/10 Boston
The Boston Deals You Missed During the Holidays: Cash for Kala Pharma, Funds for ViewFinity, Silver for SCVNGR, & More 01/04/10 Boston
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M 12/23/09 Boston
Millipore Taps Langer for Board Seat 12/16/09 Boston
Taris Biomedical, MIT Spinoff With Bladder Drug Device, Leaps Ahead To Mid-Stage Trial 12/02/09 Boston
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
The Kauffman Foundation: Bringing Entrepreneurship Up to Date in Kansas City 10/16/09 National
MIT Plans New Online Publication About Entrepreneurship 10/08/09 Boston
A123 Plans $200M+ IPO, Seaside Sees $30M, Verivue Grabs $20.1M, & More Boston-Area Deals News 09/18/09 Boston
Living Proof Lathers $9M in Fresh Capital into Beauty Products Operation 06/19/09 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.